PARIS, February 05, 2026--(BUSINESS WIRE)--BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ ...
PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and ...
BrightHeart has raised €11m ($12.8m) in funding to advance commercialisation efforts for its artificial intelligence (AI)-based prenatal congenital heart defect (CHD) screening platform. The French ...
PARIS--(BUSINESS WIRE)--BrightHeart, a Paris-based company developing an AI solution for the prenatal detection of congenital heart defects, announced today the appointment of Michael Butchko as an ...
BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare's Voluson(TM) Solution Store, bringing advanced AI ...
BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results